Constrained Lipid Nanoparticles for Ligand-Free T-Cell Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nanoparticle delivery systems for T cells require high doses of nucleic acids and rely on targeting ligands, leading to challenges in achieving effective gene silencing and trafficking to immune cells.
Innovation Solution
Lipid nanoparticles formulated with conformationally constrained ionizable lipids, phospholipids, PEG-lipids, and cholesterol, which modify tropism and clearance profiles without targeting ligands, enabling efficient delivery of nucleic acids to immune cells such as T cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If targeting ligands are used to deliver nucleic acids to T cells, then delivery specificity is improved, but device complexity and manufacturing complexity increase
Solution Approach 1:
The patent removes targeting ligands from the nanoparticle composition entirely, extracting the unnecessary component that caused complexity while maintaining delivery effectiveness through optimized lipid formulations alone
Solution Approach 2:
The patent changes the chemical parameters of the lipid components, specifically using ionizable lipids with pKa values between 6-8 and controlled hydrophobicity (logP 2-5), to achieve both targeted delivery and reduced complexity without requiring additional targeting molecules
2Reliability
If high doses of nucleic acids are administered to achieve gene silencing, then gene silencing efficacy is improved, but loss of substance and toxicity increase
Solution Approach 1:
The patent optimizes the physical-chemical parameters of the lipid nanoparticle, including ionizable lipid composition (30-70 mol%), cholesterol content (20-50 mol%), and particle size (50-200 nm), to enhance nucleic acid delivery efficiency and achieve gene silencing at lower doses
Solution Approach 2:
The patent creates a composite lipid nanoparticle system combining ionizable lipids, phospholipids, cholesterol, and PEG-lipids in specific ratios to improve nucleic acid encapsulation, stability, and cellular uptake, thereby reducing the required dosage
3Ease of manufacture
If natural trafficking pathways are used for nanoparticle delivery, then ease of manufacture is improved, but delivery efficiency to immune cells worsens
Solution Approach 1:
The patent modifies the chemical parameters of the lipid components, particularly using ionizable lipids with specific pKa ranges and hydrophobicity values, to alter the nanoparticle's biological interaction properties and achieve immune cell targeting without complex modifications
Solution Approach 2:
The patent designs a universal lipid nanoparticle platform that can deliver various nucleic acids (siRNA, mRNA, DNA) to different immune cell types using the same base composition, achieving multi-functionality without requiring cell-specific adaptations
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The lipid nanoparticles achieve significant gene silencing in T cells at lower doses, reducing splenic and hepatic clearance, and demonstrate size-independent tropism, enhancing delivery efficiency.
Implementation Method 1
it has been discovered that conformationally constrained ionizable lipids can modify the tropism and clearance profile of lipid nanoparticles without the need of a targeting ligand
Implementation Method 2
Compositions for delivering nucleic acids to specific cells or tissue microenvironments are provided. In one embodiment, the compositions are lipid nanoparticle compositions formulated to have reduced splenic and hepatic clearance
Data Source
AI summary
Compositions for delivering nucleic acids to cells or tissue microenvironments are provided. In one embodiment, the compositions are lipid nanoparticle compositions formulated to have reduced splenic and hepatic clearance. It has been discovered that the chemical composition of lipid nanoparticles significantly influences the natural trafficking of the lipid nanoparticles. More specifically, it has been discovered that conformationally constrained ionizable lipids can modify the tropism and clearance profile of lipid nanoparticles without the need of a targeting ligand. It has also been discovered that tropism of the disclosed lipid nanoparticles is size-independent.